Even during my university days, I would find myself grasping my chest, wheezing after a short 15-minute walk to campus. In terms of fitness, I would consider myself to…
November 11, 2021
In this episode, we revisit Valeo Pharma (VPH.C) to get an update on their product portfolio, stock price, and financials. Is VPH.C a good long term investment? Tune In!…
Valeo Pharma (VPH.C) is a specialty pharmaceutical company, engages in the acquisition, in-licensing, and commercialization of pharmaceutical products with a primary focus on neurodegenerative diseases, oncology and supportive care, and…
Welcome to Equity.Guru’s Roundtable where our writers weigh in on the pros and cons of a spotlight company, break out where they see value, and help you avoid public…
Valeo Pharma (VPH.C) is a specialty pharmaceutical company that sources, acquires, or in-licenses brand and generic products for sale in Canada. Valeo’s business objective is to become an anchor…
Jody catches up with the CEO of Valeo Pharma (VPH.C), Steve Saviuk, to talk more about their specialty product. Redesca, and Asthma products, Enerzair® breezhaler® and Atectura® breezhaler®. Based…